Recombinant multi-species HNRNPC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HNRNPC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene belongs to the subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene can act as a tetramer and is involved in the assembly of 40S hnRNP particles. Multiple transcript variants encoding at least two different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: C1,C2,D14Wsu171e,HNRNP,HNRNPC,HNRPC,Heterogeneous nuclear ribonucleoproteins C1/C2,Hnrnpc,Hnrpc,Hnrpc1,Hnrpc2,MRD74,SNRPC,hnRNP C,hnRNP C1/C2,hnRNPC1,hnRNPC2,hnrnp-C

Target products collectionGo to HNRNPC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7976-Ag-1/ GM-Tg-hg-IP7976-Ag-2 Human HNRNPC protein Human
GM-Tg-rg-IP7976-Ag-1/ GM-Tg-rg-IP7976-Ag-2 Rat HNRNPC protein Rat
GM-Tg-mg-IP7976-Ag-1/ GM-Tg-mg-IP7976-Ag-2 Mouse HNRNPC protein Mouse
GM-Tg-cynog-IP7976-Ag-1/ GM-Tg-cynog-IP7976-Ag-2 Cynomolgus/Rhesus macaque HNRNPC protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7976-Ag-1/ GM-Tg-felg-IP7976-Ag-2 Feline HNRNPC protein Feline
GM-Tg-cang-IP7976-Ag-1/ GM-Tg-cang-IP7976-Ag-2 Canine HNRNPC protein Canine
GM-Tg-bovg-IP7976-Ag-1/ GM-Tg-bovg-IP7976-Ag-2 Bovine HNRNPC protein Bovine
GM-Tg-equg-IP7976-Ag-1/ GM-Tg-equg-IP7976-Ag-2 Equine HNRNPC protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7976-Ag-1/ GM-Tg-hg-IP7976-Ag-2; GM-Tg-rg-IP7976-Ag-1/ GM-Tg-rg-IP7976-Ag-2;
GM-Tg-mg-IP7976-Ag-1/ GM-Tg-mg-IP7976-Ag-2; GM-Tg-cynog-IP7976-Ag-1/ GM-Tg-cynog-IP7976-Ag-2;
GM-Tg-felg-IP7976-Ag-1/ GM-Tg-felg-IP7976-Ag-2; GM-Tg-cang-IP7976-Ag-1/ GM-Tg-cang-IP7976-Ag-2;
GM-Tg-bovg-IP7976-Ag-1/ GM-Tg-bovg-IP7976-Ag-2; GM-Tg-equg-IP7976-Ag-1/ GM-Tg-equg-IP7976-Ag-2
Products Name HNRNPC protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name HNRNPC
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HNRNPC protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.